Form 8-K - Current report:
SEC Accession No. 0000950170-25-099185
Filing Date
2025-07-28
Accepted
2025-07-28 16:15:34
Documents
12
Period of Report
2025-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtsr-20250728.htm   iXBRL 8-K 49829
2 EX-99.1 mtsr-ex99_1.htm EX-99.1 264775
3 GRAPHIC img124768095_0.jpg GRAPHIC 685887
  Complete submission text file 0000950170-25-099185.txt   1382440

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mtsr-20250728.xsd EX-101.SCH 25798
14 EXTRACTED XBRL INSTANCE DOCUMENT mtsr-20250728_htm.xml XML 4891
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 251155822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)